Gene therapy guidelines revised.
D000243:Adenosine Deaminase / Q000172:deficiency; D026683:Advisory Committees; D032761:Animal Experimentation; D000818:Animals; D004285:Dogs; D028744:Ethics Committees, Research; D035082:Federal Government; D030342:Genetic Diseases, Inborn; D005818:Genetic Engineering; D033161:Government Regulation; D006801:Humans; D051379:Mice; D009316:National Institutes of Health (U.S.); D014481:United States
D000243:Adenosine Deaminase